Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways.

Lee, S-H; Bahn, J H; Whitlock, N C; Baek, S J

Lee, S-H; Bahn, J H; Whitlock, N C; Baek, S J.

Affiliation

Lee SH; Department of Pathobiology, Laboratory of Environmental Carcinogenesis, College of Veterinary Medicine, University of Tennessee, Knoxville, TN, USA.

Oncogene ; 29(37): 5182-92, 2010 Sep 16.

Article in En | MEDLINE | ID: mdl-20581861

Subject(s)

Activating Transcription Factor 2/physiology; Activating Transcription Factor 3/genetics; Gene Expression Regulation/drug effects; MAP Kinase Signaling System; ortho-Aminobenzoates/pharmacology; Activating Transcription Factor 2/genetics; Base Sequence; Cell Line, Tumor; Colorectal Neoplasms/metabolism; Colorectal Neoplasms/pathology; DNA; Humans; Phosphorylation; Promoter Regions, Genetic

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression Regulation / MAP Kinase Signaling System / Activating Transcription Factor 2 / Activating Transcription Factor 3 / Ortho-Aminobenzoates Type of study: Prognostic_studies Limits: Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2010 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google